Advertisement

Topics

Checkpoint Inhibitors Improve Outcomes of Renal Cell Cancer

19:01 EST 8 Nov 2017 | Cancer Connect

Opdivo (nivolumab) a novel “checkpoint” inhibitor immunotherapy has been demonstrated to produce superior three year survival benefit for patients with […]

The post Checkpoint Inhibitors Improve Outcomes of Renal Cell Cancer appeared first on .

Original Article: Checkpoint Inhibitors Improve Outcomes of Renal Cell Cancer

NEXT ARTICLE

More From BioPortfolio on "Checkpoint Inhibitors Improve Outcomes of Renal Cell Cancer"

Advertisement
Quick Search
Advertisement
Advertisement